$40 MILLION TRANSACTION FOR THE PHARMACEUTICAL COMPANY LSL LABORATORY INC.
$40 MILLION TRANSACTION FOR THE PHARMACEUTICAL COMPANY LSL LABORATORY INC.
On March 30, 2021, the public company Iledor Exploration Corporation, whose securities are traded on the TSX Venture Exchange, and the private company LSL Laboratory Inc., a company specializing in eye ointments and vitamins, announced the signing of a Letter of Intent for a $40 million transaction to combine and create a larger pharmaceutical company. Séguin Racine’s Mergers & Acquisitions team worked on this transaction.
